Hackensack Meridian CDI Scientists Discover New Tuberculosis   

Hackensack Meridian CDI Scientists Discover New Tuberculosis Treatment Pathway

June 29, 2021

The compound TA-C is metabolized by TB bacteria – weakening the germ from within like a ‘Trojan horse’ attack

Scientists from the Hackensack Meridian Center for Discovery and Innovation, working with collaborators from across the globe, uncovered the mechanism of action of a novel anti-tuberculosis drug that they have helped develop.

Read more

Cookie Consent

Our website uses cookies. Please review our Privacy Policy to find out more about the cookies we use. Browsing our website means you accept these terms.